The Epidemiology of Chickenpox in England, 2016-2022: An Observational Study Using General Practitioner Consultations.
chickenpox
general practitioner
primary care
syndromic surveillance
vaccination
varicella
varicella-zoster
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
27 Oct 2023
27 Oct 2023
Historique:
received:
26
09
2023
revised:
24
10
2023
accepted:
25
10
2023
medline:
27
11
2023
pubmed:
25
11
2023
entrez:
25
11
2023
Statut:
epublish
Résumé
Chickenpox is a common childhood disease caused by varicella-zoster virus (VZV). VZV vaccination is not part of the UK childhood immunisation programme, but its potential inclusion is regularly assessed. It is therefore important to understand the ongoing burden of VZV in the community to inform vaccine policy decisions. General practitioner (GP) chickenpox consultations were studied from 1 September 2016 to 9 December 2022. Over the study period, the mean weekly chickenpox consultation rate per 100,000 population in England was 3.4, with a regular peak occurring between weeks 13 and 15. Overall, rates decreased over time, from a mean weekly rate of 5.5 in 2017 to 4.2 in 2019. The highest mean weekly rates were among children aged 1-4 years. There was no typical epidemic peak during the COVID-19 pandemic, but in 2022, rates were proportionally higher among children aged < 1 year old compared to pre-pandemic years. Chickenpox GP consultation rates decreased in England, continuing a longer-term decline in the community. The COVID-19 pandemic impacted rates, likely caused by the introduction of non-pharmaceutical interventions to prevent SARS-CoV-2 transmission. The lasting impact of the interruption of typical disease transmission remains to be seen, but it is important to monitor the chickenpox burden to inform decisions on vaccine programmes.
Identifiants
pubmed: 38005841
pii: v15112163
doi: 10.3390/v15112163
pmc: PMC10674747
pii:
doi:
Substances chimiques
Chickenpox Vaccine
0
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Yearb Med Inform. 2021 Aug;30(1):44-55
pubmed: 33882603
Clin Infect Dis. 2021 Dec 6;73(11):e3617-e3626
pubmed: 33173938
J Infect. 2016 Sep;73(3):241-53
pubmed: 27283754
Lancet Infect Dis. 2023 Jan;23(1):56-66
pubmed: 36063828
BMC Infect Dis. 2016 Nov 10;16(1):666
pubmed: 27832745
Emerg Med J. 2020 Oct;37(10):600-604
pubmed: 32948621
Br J Gen Pract. 2021 Feb 25;71(704):e166-e177
pubmed: 33558332
Euro Surveill. 2021 Mar;26(11):
pubmed: 33739255
Lancet. 2011 Nov 26;378(9806):1833-4
pubmed: 22118433
JMIR Public Health Surveill. 2022 Dec 19;8(12):e39141
pubmed: 36534462
BMC Public Health. 2021 Nov 5;21(1):2019
pubmed: 34740346
Euro Surveill. 2019 Oct;24(42):
pubmed: 31640840
BMJ. 2021 Mar 24;372:n819
pubmed: 33762256
Wkly Epidemiol Rec. 2014 Jun 20;89(25):265-87
pubmed: 24983077
Arch Dis Child. 2016 Jan;101(1):2-3
pubmed: 26342095
Commun Dis Public Health. 2000 Sep;3(3):213-5
pubmed: 11014039
Clin Exp Pediatr. 2022 Dec;65(12):555-562
pubmed: 36457198
BMC Public Health. 2022 Dec 12;22(1):2318
pubmed: 36510205
Clin Infect Dis. 2021 Jun 15;72(12):2199-2202
pubmed: 32986804
Epidemiol Infect. 2017 Oct;145(13):2678-2682
pubmed: 28853391
Br J Gen Pract. 2006 Nov;56(532):820-4
pubmed: 17132347